{"Title": "Next-generation sequencing identifies a novel ELAVL1\u2013TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208", "Year": 2016, "Source": "Leuk. Lymphoma", "Volume": "57", "Issue": 12, "Art.No": null, "PageStart": 2927, "PageEnd": 2929, "CitedBy": 5, "DOI": "10.3109/10428194.2016.1171861", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84969204345&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Biphenyl Compounds", "Cell Line, Tumor", "Drug Resistance, Neoplasm", "ELAV-Like Protein 1", "Gene Expression Regulation, Leukemic", "High-Throughput Nucleotide Sequencing", "Humans", "Leukemia, Myeloid, Acute", "Oncogene Proteins, Fusion", "Protein Kinase Inhibitors", "Thiazolidines", "TYK2 Kinase"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84969204345", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"7003767994": {"Name": "Tron A.E.", "AuthorID": "7003767994", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "6507312463": {"Name": "Keeton E.K.", "AuthorID": "6507312463", "AffiliationID": "114407111", "AffiliationName": "N-of-One, Inc"}, "24492626500": {"Name": "Ye M.", "AuthorID": "24492626500", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "35084844100": {"Name": "Casas-Selves M.", "AuthorID": "35084844100", "AffiliationID": "60101854", "AffiliationName": "Drug Discovery Program, Ontario Institute for Cancer Research"}, "16201716200": {"Name": "Chen H.", "AuthorID": "16201716200", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "24780554400": {"Name": "Dillman K.S.", "AuthorID": "24780554400", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "6506563050": {"Name": "Zinda M.", "AuthorID": "6506563050", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "56612837200": {"Name": "Lai Z.", "AuthorID": "56612837200", "AffiliationID": "60004219", "AffiliationName": "Oncology iMed, AstraZeneca"}, "57058617100": {"Name": "Huszar D.", "AuthorID": "57058617100", "AffiliationID": "60028752", "AffiliationName": "Oncology Drug Discover Unit, Takeda Pharmaceuticals International Co"}, "7202817451": {"Name": "Gale R.E.", "AuthorID": "7202817451", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London Cancer Institute"}, "14826256600": {"Name": "Stengel C.", "AuthorID": "14826256600", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London Cancer Institute"}, "14634099500": {"Name": "Linch D.C.", "AuthorID": "14634099500", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London Cancer Institute"}, "7005296444": {"Name": "Khwaja A.", "AuthorID": "7005296444", "AffiliationID": "60022148", "AffiliationName": "Department of Haematology, University College London Cancer Institute"}}}